Sidoti Csr Has Pessimistic View of Cibus FY2025 Earnings

Cibus, Inc. (NASDAQ:CBUS) – Equities researchers at Sidoti Csr reduced their FY2025 earnings per share (EPS) estimates for Cibus in a research note issued on Monday, November 17th. Sidoti Csr analyst A. Hantman now anticipates that the company will post earnings of ($2.04) per share for the year, down from their prior estimate of ($1.97). The consensus estimate for Cibus’ current full-year earnings is ($2.96) per share. Sidoti Csr also issued estimates for Cibus’ Q4 2025 earnings at ($0.46) EPS, Q1 2026 earnings at ($0.35) EPS, Q4 2026 earnings at ($0.25) EPS, FY2026 earnings at ($1.20) EPS and FY2027 earnings at ($0.91) EPS.

Separately, Weiss Ratings restated a “sell (e+)” rating on shares of Cibus in a research report on Wednesday, October 8th. Two research analysts have rated the stock with a Buy rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus price target of $21.25.

Cibus Trading Down 2.3%

Shares of CBUS stock opened at $1.27 on Thursday. Cibus has a 1 year low of $1.09 and a 1 year high of $4.96. The firm’s 50 day moving average is $1.42 and its 200-day moving average is $1.65. The firm has a market capitalization of $68.94 million, a price-to-earnings ratio of -0.39 and a beta of 1.62.

Cibus (NASDAQ:CBUS) last issued its quarterly earnings results on Thursday, November 13th. The company reported ($0.44) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.41) by ($0.03). The company had revenue of $0.62 million for the quarter, compared to analyst estimates of $1.39 million. Cibus had a negative return on equity of 133.90% and a negative net margin of 3,133.92%.

Hedge Funds Weigh In On Cibus

Several large investors have recently bought and sold shares of CBUS. Armistice Capital LLC acquired a new stake in Cibus during the 1st quarter worth $3,643,000. Gratia Capital LLC acquired a new stake in shares of Cibus during the second quarter worth $1,183,000. Jane Street Group LLC bought a new stake in Cibus in the second quarter valued at about $207,000. Certior Financial Group LLC lifted its stake in Cibus by 72.2% in the first quarter. Certior Financial Group LLC now owns 146,348 shares of the company’s stock valued at $274,000 after buying an additional 61,363 shares during the period. Finally, Squarepoint Ops LLC bought a new position in Cibus during the third quarter worth about $62,000. 33.81% of the stock is currently owned by institutional investors and hedge funds.

Cibus Company Profile

Cibus, Inc, a agricultural biotechnology company, develops and licenses plant traits to seed companies for royalties. The company primarily focus on trait productivity in two areas, including productivity traits that enable farmers to have higher yields and reduce the use of the crop protection chemicals and fertilizers; and sustainable ingredients that enable corporations to replace ingredients that are fossil fuel based or whose production results in increased greenhouse gases.